Enhanced Healthcare Partners, a New York-based private equity firm, and Bourne Partners, an investment firm, agreed to acquire Pharmaceutical Associates, a market's generic oral liquid pharmaceuticals manufacturer. Financial terms were not disclosed. “We realized we were at an important inflection point in our Company’s evolution and decided it was the right time to bring on financial partners that could help accelerate our growth. Choosing the right partner was a careful and deliberate process. It was clear from the start that EHP’s knowledge and expertise would help propel our vision forward. In addition, BPSC was instrumental in helping orchestrate this transaction, and due to their deep network in the pharmaceutical space, will be a true value-add partner. Together, we can accelerate our plans for expansion and innovation as well as attract the right talent to help grow our dynamic company. I’m truly proud to call EHP and BPSC our partners,” Kurt Orlofski, PAI CEO.